Observation of the clinical efficacy of gynecological Duanhongyin capsules in the treatment of abnormal uterine bleeding after placement of subcutaneous implanted contraceptive with pregnene

ZHU Jun; ZHANG Su-ying; FENG Jie; WU Di; YANG Yang; HUANG An-feng; JIANG Li-rong; LI Xiao-juan; HE Cha-ying

doi:10.19538/j.fk2025080116

PDF(925 KB)

Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (8) : 847-851. DOI: 10.19538/j.fk2025080116

Observation of the clinical efficacy of gynecological Duanhongyin capsules in the treatment of abnormal uterine bleeding after placement of subcutaneous implanted contraceptive with pregnene

Author information +

History +

Abstract

Objective Observation of the clinical efficacy and safety of gynecological Duanhongyin capsules in the treatment of abnormal uterine bleeding after placement of subcutaneous implanted contraceptive with pregnene. Methods This study is a randomized controlled trial，using a numerical table method to randomly select 60 patients from the Family Planning Center of Hangzhou Obstetrics and Gynecology Hospital from August 2022 to November 2024 who experienced abnormal uterine bleeding after receiving subcutaneous implantation of etoposide contraceptive，divided into a treatment group and a control group，with 30 cases in each group.The control group did not receive any medication intervention treatment except for counseling and comfort. The research group added gynecological Duanhongyin capsules for treatment. Observe the effective rate of two treatment groups，the duration of abnormal uterine bleeding and vaginal bleeding，the recurrence rate of abnormal uterine bleeding，the continuation rate of subcutaneous implant contraception，hormone levels in the body，and endometrial thickness，and conduct safety evaluation. Results The total effective rate of clinical treatment in the research group was 86.67%，significantly higher than the control group's 3.33% （P<0.001）；The median number of vaginal bleeding days in the first month after medication was 5.5 （4.0，10.0），the median number of vaginal bleeding days in the second month after medication was 5.0 （4.0，10.0），and the median number of vaginal bleeding days in the third month after medication was 5.0 （4.0，8.5），all of which showed statistically significant differences compared to the control group （P<0.001）.The recurrence rate of abnormal uterine bleeding after 3 months of observation and treatment was 20.00% in the study group （100.00% in the control group），and the follow-up removal rate was only 36.67% in the study group （96.67% in the control group），with significant statistical differences （all P<0.001）. The incidence of complications and other adverse events was similar between the study group and the control group，with no statistically significant differences （all P>0.05）. Conclusion Gynecological Duanhongyin capsules have shown significant clinical efficacy and medication safety in treating abnormal uterine bleeding caused by subcutaneous implantation of contraceptive agents.

Key words

gynecological Duanhongyin capsules / subcutaneous implantation of contraceptive based on pregnene / abnormal uterine bleeding.

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHU Jun , ZHANG Su-ying , FENG Jie , et al . Observation of the clinical efficacy of gynecological Duanhongyin capsules in the treatment of abnormal uterine bleeding after placement of subcutaneous implanted contraceptive with pregnene[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2025, 41(8): 847-851 https://doi.org/10.19538/j.fk2025080116

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	Oliveira JA, Neves GL, Pinhati MES, et al. Subdermal implants vs. levonorgestrel intrauterine devices outcomes in reproductive-aged women:a systematic review and meta-analysis[J]. Arch Gynecol Obstet, 2025, 311(4):1173-1180. DOI:10.1007/s00404-025-07943-6. Cited in this article [1]

[2]

Capobianco

, Sanna

, Gulotta

, et al. Use of etonogestrel subcutaneous implant in Sardinia,Italy:women’s compliance and satisfaction[J]. Eur J Contracept Reprod Health Care, 2024, 29(4):171-176. DOI:10.1080/13625187.2024.2354248.

https://www.tandfonline.com/doi/full/10.1080/13625187.2024.2354248

Cited in this article [1]

[3]	Rocca ML, Palumbo AR, Visconti F, et al. Safety and benefits of contraceptives implants:a systematic review[J]. Pharmaceuticals(Basel), 2021, 14(6):548. DOI:10.3390/ph14060548. Cited in this article [1]

[4]

Sinthuchai

, Tapanwong

, Apirakviriya

, et al. Effect of a single dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s)users:A randomized double-blind placebo-controlled trial[J]. Contraception, 2024, 131:110354. DOI:10.1016/j.contraception.2023.110354.

https://linkinghub.elsevier.com/retrieve/pii/S0010782423004821

Cited in this article [1]

[5]	皮下埋植避孕方法临床应用中国专家共识组. 皮下埋植避孕方法临床应用专家共识[J]. 中华妇产科杂志, 2013, 6(48):476-480. DOI:10.3760/cma.j.issn.0529-567X.2013.06.019. Cited in this article [2]

[6]

Zheng

, Tang

, Wang

, et al. Three-year observational study of immediate post-abortion insertion versus menstrual insertion of etonogestrel contraceptive implant[J]. BMC Women's Health, 2021, 21(1):436. DOI:10.1186/s12905-021-01542-8.

Cited in this article [1] Abstract

This study aimed to estimate the difference in vaginal bleeding pattern, discontinuation rate, and satisfaction between immediate after abortion and menstrual insertions of etonogestrel contraceptive implants.

[7]

Jaisamrarn

, Santipap

, Santibenchakul

. Discontinuation rates of different contraceptive methods in Thai women up to 1-year after method initiation[J]. Sci Rep, 2021, 11(1):10819. DOI:10.1038/s41598-021-90373-6.

https://www.ncbi.nlm.nih.gov/pubmed/34031521

Cited in this article [2] Abstract

We assessed the discontinuation rate and the reason for discontinuation of common contraceptives used by reproductive-aged Thai women. We recruited 1880 women aged 18-45 years from the Family Planning Clinic of the Chulalongkorn Hospital in Bangkok. The participants were followed at three, six and twelve months. A Cox proportional hazards model was used to determine personal risks of discontinuing contraceptives. The incidence rate for discontinuation of combined oral contraceptive pills (COCs), depot medroxyprogesterone acetate (DMPA), copper intrauterine device (IUD), and contraceptive implant(s) were 21.3, 9.2, 4.4, and 2.3/100 person-years, respectively. Most of the women who discontinued (185/222) discontinued contraceptives due to side effects. Compared to contraceptive implant users, the adjusted hazard ratios (aHRs) [95% confidence intervals (CIs)] of discontinuing COCs, DMPA, and the copper IUD were 9.6 (4.3-21.8), 4.2 (1.8-10.0), and 2.2 (0.8-5.9), respectively. Lower income, higher parity, history of miscarriage, and history of abortion were independent predictors of contraceptive discontinuation in a multivariable model.

[8]

Green

, Sheeder

, Richards

. The etonogestrel implant in adolescents:factors associated with removal for bothersome bleeding in the first year after insertion[J]. J Pediatr Adolescent Gynecol, 2021, 34(6):825-831. DOI:10.1016/j.jpag.2021.05.011.

https://linkinghub.elsevier.com/retrieve/pii/S1083318821002138

Cited in this article [1]

[9]	Moeti DMP, Govender I, Bongongo T. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria[J]. S Afr Fam Pract(2004), 2022, 64(1):e1-e6. DOI:10.4102/safp.v64i1.5407. Cited in this article [1]

[10]	Hu Y, Zhou K, Shan D, et al. Interventions for vaginal bleeding irregularities with contraceptive implant[J]. Cochrane Database Syst Rev, 2021, 2021(3):CD014649. DOI:10.1002/14651858.cd014649. Cited in this article [1]

[11]	贺芳, 陈敦金. 氨甲环酸在产后出血中应用的研究进展[J]. 中华产科急救电子杂志, 2024, 13(1):55-59. DOI:10.3877/cma.j.issn.2095-3259.2024.01.010. Cited in this article [1]

[12]

Guiahi

, McBride

, Sheeder

, et al. Short-term treatment of bothersome bleeding for etonogestrel implant users using a 14-day oral contraceptive pill regimen:a randomized controlled trial[J]. Obstet Gynecol, 2015, 126(3):508-513. DOI:10.1097/AOG.0000000000000974.

https://journals.lww.com/00006250-201509000-00009

Cited in this article [1]

[13]	Teal S, Edelman A. Contraception selection, effectiveness,and adverse effects:a review[J]. JAMA, 2021, 326(24):2507-2518. DOI:10.1001/jama.2021.21392. https://jamanetwork.com/journals/jama/fullarticle/2787541 Cited in this article [1]

[14]	汤艳莉, 郭重威. 中医辨治月经失调的临床研究进展[J]. 国际中医中药杂志, 2017, 39(9):859-862. DOI:10.3760/cma.j.issn.1673-4246.2017.09.026. Cited in this article [1]

[15]	黄健, 陈怡, 陈颐. 岭南名中医黄健玲教授治疗崩漏经验[J]. 国际医药卫生导报, 2021, 27(14):2072-2074. DOI:10.3760/cma.j.issn.1007-1245.2021.14.004. Cited in this article [1]

[16]	张莹, 张迪. 中医药治疗崩漏的研究进展[J]. 国际医药卫生导报, 2021, 27(14):2208-2211. DOI:10.3760/cma.j.issn.1007-1245.2021.14.044. Cited in this article [1]

[17]	丁宁, 王晓梅, 徐世杰. 基于网络药理学探讨赤芍-牡丹皮药对治疗异常子宫出血的作用机制[J]. 海南医学院学报, 2021, 27(18):1408-1415,1425.DOI:10.13210/j.cnki.jhmu.20200814.003. Cited in this article [1]

[18]	张靖, 李潇. 三七总皂苷对流产大鼠子宫出血的影响及子宫内膜修复作用机制的研究[J]. 天津医药, 2022, 50(4):375-380.DOI:10.11958/20211671. Cited in this article [1]

[19]	夏宛廷, 邓琳雯, 石玲, 等. 益母草注射液对排卵障碍性异常子宫出血止血疗效观察[J]. 中国实用妇科与产科杂志, 2020, 36(12):1196-1199.DOI:10.19538/j.fk2020120117. Cited in this article [1]

[20]	师玉玉, 邵奇, 刘莹, 等. 国医大师王庆国临证运用仙鹤草经验[J]. 吉林中医药, 2025, 45(1):42-45.DOI:10.13463/j.cnki.jlzyy.2025.01.011. Cited in this article [1]

[21]	陈文鹏, 卢健棋, 庞延, 等. 仙鹤草化学成分、药理作用及临床应用研究进展[J]. 辽宁中医药大学学报, 2022, 24(6):118-122.DOI:10.13194/j.issn.1673-842x.2022.06.026. Cited in this article [1]

[22]	何璎, 赵洪庆, 吴梦瑶, 等. 基于网络药理学及实验验证探究妇科断红饮胶囊治疗功能失调性子宫出血的作用机制[J]. 世界科学技术-中医药现代化, 2022, 24(11):4444-4454.DOI:10.11842/wst.20210923006. Cited in this article [1]